Weegen Felice Isabel Verduyn-van
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 2 boards, counting each seat separately. Longest: Evommune Inc., 10 months.
Evommune Inc.
Director
AgomAb Therapeutics NV
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 7, 2025 | Evommune Inc. | Derivative conversion | +3,367,133 | — | — |
| Nov 7, 2025 | Evommune Inc. | Open-market purchase | +1,562,500 | $16.00 | $25,000,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.